Background and aims Lipoprotein (a)[Lp (a)] is an emerging genetic risk factor for
cardiovascular disease (CVD). We examined whether plasma Lp (a) concentration and …

Abstract Background Lipoprotein (a)(Lp [a]) is a causal genetic risk factor for atherosclerotic
cardiovascular disease (ASCVD). There are limited long-term follow-up data from large US …

Lipoprotein (a)[Lp (a)], is present only in humans, Old World nonhuman primates, and the
European hedgehog. Lp (a) has many properties in common with low-density lipoprotein …

The aim of this review is to summarize present evidence of a causal association of
lipoprotein (a) with risk of ischemic heart disease (IHD). Evidence for causality includes …

OBJECTIVE: A minor allele variant (rs3798220) of apolipoprotein (a) has been reported to
be associated with elevated plasma lipoprotein (a)[Lp (a)] and increased cardiovascular risk …

Background In recent years, lipoprotein (a)(Lp (a)) has been recognized as an important risk
factor for cardiovascular disease (CVD). A variant in the LPA gene, rs10455872, has been …

Background: Genomic analyses have suggested that the LPA gene and its associated
plasma biomarker, lipoprotein (a)(Lp [a]), represent a causal risk factor for coronary heart …

Aims The relevance of lipoprotein (a)[Lp (a)] concentrations and low-molecular-weight
(LMW) apo (a) phenotypes in peripheral arterial disease (PAD) has only been investigated …

Lipoprotein (a)[Lp (a)] has attracted the interest of researchers and physicians due to its
intriguing properties, including an intragenic multiallelic copy number variation in the LPA …

High levels of lipoprotein (a)[Lp (a)], an apoB100-containing lipoprotein, are an independent
and causal risk factor for atherosclerotic cardiovascular diseases through mechanisms …